Cite
Therapeutic Potential of Ixekizumab in the Treatment of Ankylosing Spondylitis: A Review on the Emerging Clinical Data
MLA
Benucci,Maurizio, et al. “Therapeutic Potential of Ixekizumab in the Treatment of Ankylosing Spondylitis: A Review on the Emerging Clinical Data.” Therapeutics and Clinical Risk Management, Apr. 2020. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.dovemedicalp..2e83abc418717b3eff4b16ea683facfb&authtype=sso&custid=ns315887.
APA
Benucci,Maurizio, Damiani,Arianna, Li Gobbi, F., Grossi,Valentina, Infantino,Maria, Manfredi,Mariangela, Niccoli,Laura, & Cantini,Fabrizio. (2020). Therapeutic Potential of Ixekizumab in the Treatment of Ankylosing Spondylitis: A Review on the Emerging Clinical Data. Therapeutics and Clinical Risk Management.
Chicago
Benucci,Maurizio, Damiani,Arianna, Francesca Li Gobbi, Grossi,Valentina, Infantino,Maria, Manfredi,Mariangela, Niccoli,Laura, and Cantini,Fabrizio. 2020. “Therapeutic Potential of Ixekizumab in the Treatment of Ankylosing Spondylitis: A Review on the Emerging Clinical Data.” Therapeutics and Clinical Risk Management, April. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.dovemedicalp..2e83abc418717b3eff4b16ea683facfb&authtype=sso&custid=ns315887.